Cytosorbents Corp
CTSO
91 hedge funds and large institutions have $111M invested in Cytosorbents Corp in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 13 reducing their positions, and 14 closing their positions.
192% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 13
118% more call options, than puts
Call options by funds: $2.27M | Put options by funds: $1.04M
71% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 14
45% more capital invested
Capital invested by funds: $76.8M → $111M (+$34.5M)
11% more funds holding
Funds holding: 82 → 91 (+9)
2.72% more ownership
Funds ownership: 28.4% → 31.12% (+2.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$2.09M |
| 2 |
BlackRock
New York
|
+$1.74M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.68M |
| 4 |
Goldman Sachs
New York
|
+$1.03M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$782K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$966K |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$933K |
| 3 |
Morgan Stanley
New York
|
-$845K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$586K |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$538K |
CTSO Hedge Fund Activity: Q2 2020 in Review
91 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2020, worth a combined $111M — up 45% from $76.8M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new CTSO positions and 14 closed out — a net gain of 10 holders — while 38 added to existing stakes and 13 trimmed.
The largest buyer was Sargent Investment Group, adding an estimated $2.09M. The largest seller was Manatuck Hill Partners, exiting entirely with an estimated $966K sold.
- 91 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2020, up from 82 in Q1 2020.
- Funds reported $111M of Cytosorbents Corp stock for Q2 2020, up 45% quarter-over-quarter.
- 24 funds opened new Cytosorbents Corp positions in Q2 2020 and 14 closed out, a net change of +10 holders.
- The largest Cytosorbents Corp buyer in Q2 2020 was Sargent Investment Group, an estimated $2.09M added.
- The largest Cytosorbents Corp seller in Q2 2020 was Manatuck Hill Partners, an estimated $966K sold.
Based on aggregated 13F filings for Q2 2020.